...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Fasting versus Nonfasting Triglycerides and the Prediction of Cardiovascular Risk: Do We Need to Revisit the Oral Triglyceride Tolerance Test?
【24h】

Fasting versus Nonfasting Triglycerides and the Prediction of Cardiovascular Risk: Do We Need to Revisit the Oral Triglyceride Tolerance Test?

机译:空腹与非空腹甘油三酸酯和心血管风险的预测:我们是否需要重新进行口服甘油三酸酯耐受性测试?

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Historically, triglycerides have been measured in the fasting state for 2 reasons. First, because of the marked increase in triglycerides after fat ingestion, the variability in triglyceride measurements is much smaller in the fasting state. Second, before the availability of direct assays for LDL cholesterol (LDL-C),1 estimation of LDL-C was performed in clinical practice almost exclusively by use of the Friedewald equation, which requires that both the HDL-C concentration and the fasting triglyceride concentration divided by 5 be subtracted from the total cholesterol concentration.The recommendations to measure triglycerides in the fasting state did not, however, derive from a consistent set of prospective cohort studies showing that fasting concentrations were superior to nonfasting concentrations for the detection of cardiovascular risk. Instead, following screening guidelines, most epidemiologic investigations simply relied on fasting triglycerides. Taken as a whole, such studies indicate that fasting triglycerides are a univariate predictor of vascular disease. Controversy exists, however, regarding the clinical usefulness of fasting triglycerides as an independent predictor of risk, because adjustment for other covariates—in particular HDL-C—markedly decreases both the magnitude and significance of observed epidemiologic effects (1). The extent to which investigators have sought to avoid nonfasting triglycerides as a method for risk detection is evident in a recent metaanalysis that limited evaluation only to those epidemiologic studies that measured fasting triglycerides, specifically “to exclude the possibility of postprandial effects” (2).Is it possible, then, that recommendations to measure triglycerides in the fasting state have systematically underestimated the impact of hypertriglyceridemia in clinical practice? Atherosclerosis has long been hypothesized to be a disorder influenced by postprandial effects. As early as 1950, J. R. Moreton, writing in the Journal of Laboratory and Clinical Medicine , suggested a linkage between chylomicronemia, fat tolerance, and atherosclerosis (3). A major source of circulating triglycerides is dietary …
机译:历史上,出于两个原因,已经在禁食状态下测量了甘油三酸酯。首先,由于脂肪摄入后甘油三酸酯的显着增加,因此在空腹状态下甘油三酸酯测量的变异性要小得多。其次,在可以直接检测LDL胆固醇(LDL-C)之前,1在临床实践中几乎完全通过使用Friedewald方程对LDL-C进行了估算,这需要HDL-C浓度和空腹甘油三酸酯总胆固醇浓度减去5浓度除以5。在空腹状态下测量甘油三酸酯的建议并非来自一致的前瞻性队列研究,该研究显示空腹浓度优于非空腹浓度可检测到心血管风险。取而代之的是,按照筛查指南,大多数流行病学调查仅依靠空腹甘油三酯。总的来说,此类研究表明空腹甘油三酸酯是血管疾病的单变量预测因子。然而,关于禁食甘油三酸酯作为风险的独立预测因素的临床有效性存在争议,因为对其他协变量(尤其是HDL-C)的调整显着降低了所观察到的流行病学影响的幅度和重要性(1)。在最近的荟萃分析中,研究人员试图避免使用非空腹甘油三酸酯作为风险检测方法的程度很明显,该评估仅限于那些测量空腹甘油三酸酯的流行病学研究,特别是“排除餐后影响的可能性”(2)。那么,在空腹状态下测量甘油三酸酯的建议是否可能系统地低估了高甘油三酯血症在临床实践中的影响?长期以来,人们一直认为动脉粥样硬化是受餐后影响的疾病。早在1950年,J。R. Moreton在《实验室与临床医学杂志》上发表的文章提出乳糜微粒血症,脂肪耐受性和动脉粥样硬化之间存在联系(3)。饮食中循环甘油三酸酯的主要来源是……

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号